Billmann F, Nießen A, Hackert T
Klinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Deutschland.
Chirurgie (Heidelb). 2022 Aug;93(8):758-764. doi: 10.1007/s00104-022-01630-x. Epub 2022 Apr 11.
The majority of patients with pancreatic neuroendocrine neoplasms (pNEN) already present with distant metastases at diagnosis. The heterogeneity of pNEN and the broad spectrum of treatment options make adequate patient selection and an evidence-based strategy essential. In metastatic pNEN both primary resection and resection of liver metastases have been shown to improve overall survival. Surgical treatment of liver metastases can also be carried out with palliative intent, especially for symptomatic pNEN and can have a positive effect on disease-free survival and overall survival. Classical hepatectomy techniques and innovative techniques (two-stage resections, liver transplantation) are available to the surgeon. In complex growth types of liver metastases, there is increasing evidence for a combination of surgery and ablative methods. Due to a relevant risk of recurrence following liver resection, pNEN patients need to be included in multimodal treatment concepts. Current areas of interest in the treatment of metastatic pNEN are the use of adjuvant/neoadjuvant chemotherapy and surgery in G3-NEN and G3-NEC patients. The aim of this review is to give an overview on the impact of surgery in the situation of distant metastatic NEN of the pancreas.
大多数胰腺神经内分泌肿瘤(pNEN)患者在确诊时已出现远处转移。pNEN的异质性和广泛的治疗选择使得恰当的患者选择和基于证据的策略至关重要。在转移性pNEN中,已证实原发灶切除和肝转移灶切除均可改善总生存期。肝转移灶的手术治疗也可出于姑息目的进行,尤其是对于有症状的pNEN,并且对无病生存期和总生存期可产生积极影响。外科医生可采用经典肝切除技术和创新技术(两阶段切除术、肝移植)。在肝转移灶的复杂生长类型中,越来越多的证据支持手术与消融方法联合应用。由于肝切除后存在复发的相关风险,pNEN患者需要纳入多模式治疗方案。转移性pNEN治疗当前的关注领域是G3-NEN和G3-NEC患者辅助/新辅助化疗与手术的应用。本综述的目的是概述手术在胰腺远处转移性神经内分泌肿瘤情况下的影响。